Two Seas Capital LP
Source: SEC Form 13F · as of Mar 2026Two Seas Capital LP holds 6 biotech & pharma companies tracked by BioSniper, totaling $614.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
6
Total value held
$614.9M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Roivant Sciences Ltd. (ROIV)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| ROIVRoivant Sciences Ltd. | 9,328,291 | $258.4M |
| NKTRNEKTAR THERAPEUTICS | 1,959,178 | $141.0M |
| ABUSArbutus Biopharma Corp | 18,557,543 | $83.5M |
| IMVTImmunovant, Inc. | 3,201,962 | $79.5M |
| ESPREsperion Therapeutics, Inc. | 11,394,833 | $31.2M |
| QUREuniQure N.V. | 1,300,000 | $21.3M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.